Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2024-2030

Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2024-2030

The Infection Control Market size was estimated at USD 43.62 billion in 2023 and expected to reach USD 45.79 billion in 2024, at a CAGR 5.23% to reach USD 62.36 billion by 2030.

Infection control refers to the disciplined approach and practices designed to prevent the spreading of infectious diseases. This multifaceted discipline encompasses identifying sources of infections, understanding the mechanisms through which infections spread, and implementing strategic measures to mitigate the transmission of infectious agents. It involves a combination of science, theory, and practices to protect healthcare providers, patients, and the public from the dangers of contagious diseases. The infection control market is experiencing robust growth, driven by the rise of hospital-acquired infection incidence, heightened awareness and demand for infection control amidst infectious disease outbreaks, advancements in sterilization technologies, expanding healthcare infrastructure, and stringent global regulations on infection prevention practices. Opportunities for market expansion include the development of eco-friendly disinfection methods, implementation of IoT and AI for hygiene management, entry into emerging markets with rising healthcare standards, and innovative solutions for the disposal of infectious waste. Nonetheless, challenges such as the high costs of advanced sterilization equipment, limited awareness and practice adoption in lower-income regions, healthcare worker resistance due to training deficiencies, and environmental concerns over infectious waste disposal are notable barriers. To achieve sustained growth, the sector is poised for innovation in cost-effective sterilization technologies, eco-friendly disposable products, automated and real-time infection control monitoring, and collaborative efforts to make infection control solutions more accessible and affordable worldwide.

Regional Insights

The Americas have demonstrated high adoption rates of advanced infection control technologies, driven by stringent regulatory guidelines from agencies such as the CDC and FDA. This region is home to several companies in the infection control market, contributing significantly to global production capabilities. Furthermore, there is a strong focus on research and innovation, enabling continuous advancements in infection control methods. Conversely, the APAC region is witnessing the fastest growth in this sector, attributed to rising awareness of health and hygiene practices, increasing healthcare expenditures, and expanding healthcare infrastructure, especially in countries such as China and India. The production landscape here is marked by a mix of local and international companies, with efforts to expand manufacturing capabilities to meet the growing demand. The EMEA region presents a diverse picture, with well-established infection control practices in European countries driven by healthcare regulations and high-quality standards. The Middle East and Africa, while gradually improving, face challenges related to uneven access to healthcare facilities and technologies. This region hosts a blend of domestic and international companies focusing on expanding their reach to underserved areas, underscoring the potential for growth in infection control practices.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Infection Control Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Rising incidence of hospital-acquired infections and surging usage of infection control products
Increasing number of surgical procedures and need for appropriate safety methods
Upsurging adoption of infection control products in medical device and pharmaceutical industry

Market Restraints

Adverse effects associated with chemical based disinfectants

Market Opportunities

Increasing outsourcing of sterilization services by hospitals, and clinics
Growing investments by manufacturers in the production of infection control products

Market Challenges

Availability of substitute products and techniques for infection control

Market Segmentation Analysis

Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
End-User: Evolving usage of infection control in hospitals & clinics sector

Market Disruption Analysis

Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Infection Control Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Infection Control Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Freudenberg Medical Establishes Second Production Facility In Costa Rica

Freudenberg Medical inaugurated a second production facility in Costa Rica. This new establishment, touted as a testament to Freudenberg Medical's commitment to innovation and excellence in healthcare, aims to bolster the company's capabilities in producing high-quality medical devices. The facility is a part of Freudenberg Medical's broader strategy to enhance its service offerings and efficiency in meeting the burgeoning demand for advanced medical technologies.

WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy

WPT Nonwovens announced a significant investment of USD 1.95 million to enhance its Beaver Dam, Kentucky operations. This strategic financial infusion aims to augment the company's manufacturing capabilities, specifically to produce premium, nonwoven fabrics designed for infection control. The investment underscores WPT Nonwovens' commitment to meeting the burgeoning demand for high-quality infection control solutions, marking a pivotal step in its mission to deliver superior products that cater to the evolving needs of the healthcare industry.

Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols

Berry Global introduced an innovative lightweight tube closure solution, poised to set a new benchmark in sustainability and efficiency. This forward-thinking design, which significantly reduces material usage without compromising on performance, offers a sustainable alternative to traditional models, catering to the growing demand for environmentally conscious packaging solutions in the healthcare sector. The launch underscores Berry Global's commitment to sustainable practices while catering to the stringent safety and hygiene standards mandated in infection control protocols.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Infection Control Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMérieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

Transmission
Airborne
Bloodborne
Contract
Products
Cleaning & Disinfection
Disinfectants
Hand Disinfectants
Instrument Disinfectants
Skin Disinfectants
Surface Disinfectants
Equipment
Flusher Disinfectors
Ultrasonic Cleaners
UV-Ray Disinfectors
Washer Disinfectors
Formulation
Disinfectant Sprays
Disinfectant Wipes
Liquid Disinfectants
Level of Disinfection
High-Level
Intermediate-Level
Low-Level
Endoscope Reprocessing
Consumables
Equipment
Protective Barriers
Covers & Closures
Goggles
Medical Nonwovens
Sterilization
E-Beam Sterilization
Equipment Sterilization
ETO Sterilization
Filtration Sterilization
Gamma Sterilization
Radiation Sterilization
Steam Sterilization
End-User
Food & Beverage Companies
Hospitals & Clinics
Life Sciences Industry
Medical Device Companies
Pharmaceutical Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year